| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $33.99B | +3.0% |
| R&D Expense | $147.0M | -2.0% |
| SG&A Expense | $3.43B | +2.9% |
| Operating Income | $8.92B | +3.3% |
| Interest Expense | $575.0M | +3.6% |
| Pre-tax Income | $8.90B | +3.8% |
| Income Tax | $1.99B | -0.6% |
| Net Income | $6.90B | +5.1% |
| EPS (Basic) | $14.69 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.06B | +4.2% |
| Accounts Receivable | $4.97B | +7.4% |
| Inventory | $2.06B | +5.6% |
| Current Assets | $13.32B | +2.9% |
| Total Assets | $86.82B | +8.3% |
| Current Liabilities | $15.20B | +4.5% |
| Long-term Debt | $22.48B | +29.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.35B | +9.8% |
| Capital Expenditures | $5.26B | +17.0% |
| Investing Cash Flow | -$5.72B | -23.2% |
| Financing Cash Flow | -$4.55B | -4.5% |
| Free Cash Flow | $5.09B | +3.3% |
| +7.1% |
| EPS (Diluted) | $14.61 | +7.3% |
| Total Liabilities |
| $47.08B |
| +15.8% |
| Stockholders' Equity | $38.24B | +0.4% |